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Abstract: 
Acyl CoA diacylglycerol acyltransferase (DGAT, EC 2.3.1.20) is recognized as a key player of cellular diacylglycerol 
metabolism. It catalyzes the terminal, yet the committed step in triacylglycerol synthesis using diacylglycerol and fatty acyl CoA 
as substrates. The protein sequence of diacylglycerol acyltransferse (DGAT) Type 2B in Moretierella ramanniana var. 
angulispora (Protein_ID = AAK84180.1)  was  retrieved from GenBank. However, a structure is not yet available for this 
sequence. The 3D structure of DGAT Type 2B was modeled using a template structure (PDB ID: 1K30) obtained from Protein 
databank (PDB) identified by searching with position specific iterative BLAST (PSI-BLAST). The template (PDB ID: 1K30) 
describes the structure of DGAT from Cucurbita moschata. Modeling was performed using Modeller 9v2 and protein model is 
hence generated. The DGAT type 2B protein model was subsequently docked with six inhibitors (sphingosine; trifluoroperazine; 
phosphatidic acid; lysophospatidylserine; KCl; 1, 2-diolein) using AutoDock (a molecular docking program). The binding of 
inhibitors to the protein model of DGAT type 2B is discussed. 
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Background: 
The enzyme diacylglycerol acyltransferase (DGAT) [EC 
2.3.1.20] catalyses the chain terminating step in 
triacylglycerol (TG) biosynthesis. This utilizes diacylglycerol 
(DG) as a substrate in competition with phospholipids 
biosynthesis through the Kennedy pathway. TG and 
phospholipids thus synthesized have distinct physico-
chemical characteristics that could have an impact on 
intracellular membrane biogenesis. The fatty acid profile of 
these lipids is well maintained due to the substrate 
specificities of DGAT and DG-utilizing enzymes through 
deacylation-reacylation of these lipids. TG is potentially 
synthesized and sequestered in spatial cells such as 
hepatocytes, adipocytes, plant seeds and oleaginous fungi [1 - 
4]. DGAT is assumed to be involved in the specific 
augmentation of TG accumulation in these types of cells. 
Manipulation of DGAT could regulate the quality and 
quantity of TG. However, the molecular role of DGAT is still 
unclear despite its important role in TG associated disorder of 
mammalian cells. A very few reports describe its purification
 
[5 - 7], and the purified fraction contained several peptides, 
among which the catalytic subunit remains to be identified. 
Mortierella ramanniana var. angulispora is known to 
accumulate lipids (especially TG). TG contains relatively 
large amount of γ-linolenic acid. The fungus is known as a 
potent producer of γ-linolenic acid and essential fatty acids 
by fermentation
 [8 -10]. Such oleaginous fungi are expected 
to exhibit amplified expression of specific mechanisms for 
TG biosynthesis and TG sequestration in lipid bodies taking 
advantage of oleaginicity. DGAT has been characterized in 
this fungus to explain the mechanism of TG biosynthesis and 
sequestration
 [11, 12]. DGAT activity was higher in the lipid 
body fraction as compared to that in membrane fraction. It 
has also been found that DGAT is activated by specific 
anionic phospholipids
  [13]  providing insights to the 
regulation. We reported the purification of DGAT from the 
lipid body fraction of the fungus [14]. This allowed for 
further studies on TG biosynthesis. Here, we describe the 
binding of the inhibitors with the protein model of DGAT 
type 2B. 
 
Methodology: 
DGAT sequence  
The sequence of the diacylglycerol acyltransferse (DGAT) 
type 2B from Mortierella ramanniana var. angulispora 
(Protein_ID = AAK84180.1) comprising of 355 residues was 
retrieved from GenBank.  
 
Template structure selection 
A suitable template (PDB-ID: 1K30) was selected using PSI-
BLAST  [15] search with PDB. The selected template is 
DGAT from Cucurbita moschata with more than 70% 
sequence similarity. 
 
Modeling of DGAT type 2B 
The template (1K30) and target (DGAT Type 2B) sequences 
were aligned using mGenThreader  Server. [16] After 
careful examination for the potential alignment errors, the 
automated comparative protein modeling program 
MODELLER 9v2 [17] was employed to build the model. Bioinformation by Biomedical Informatics Publishing Group               open access 
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Structure submission to Protein Model Database: 
The molecular configuration of DGAT is investigated using 
data described elsewhere [14]. The authors thus submitted the 
two protein models for DGAT as follows: (a) DGAT 2B 
model submitted to Protein Model Database in France during 
August 2007 (Protein ID: PM 0074978) and (B) DGAT 2A 
model submitted to Protein Model Database in France during 
August’ 2007 (Protein ID: PM 0074981). 
 
Discussion: 
Five theoretical models of DGAT Type 2A and Type 2B 
were generated by MODELLER. The generated models of 
DGAT Type 2A and Type 2B are represented in Figure 1(A) 
and 1(B), respectively. Among the five DGAT Type 2B 
models, the lowest energy structure was DGAT2A 1 and 
DGAT2B as shown in Figure 1(A) and 1(B), respectively. In 
order to select the best model, we checked the structural 
validity of DGAT Type 2B by PROCHECK. The torsion 
angles Φ and Ψ of 88.9% of the residues had values within 
the most favored regions and only 0.3% of the residues had 
values within disallowed regions. The overall G-factor is a 
measure of the overall normality of the structure and low G-
factors indicate that residues have unlikely conformations. 
The overall value is obtained from an average of G-factors 
for all residues in structure. X-ray structure of DGAT Type 
2A with resolution of 2.0 Å and a G-factor of 0.26 Å. The 
stereo-chemical quality of a protein model can be judged by 
the use of Φ  and  Ψ scatter plots. The incorrect structures 
generally have a larger fraction of residues in the disallowed 
regions [18]. The model of DGAT Type 2B has only 0.3% of 
its residues in the disallowed regions. Thus, the model 
satisfies criteria of a reasonably acceptable model.  
 
The catalytic mechanisms of DGAT in various fungi are 
similar. However, they show significantly different substrate 
specificities in various species. The active site of DGAT 
Type 2B was hypothecated into two regions: (a) catalytic site 
and (b) primer binding site. The mechanism of action of 
DGAT involves a catalytic triad composed of an asparagine, 
a histidine, and the catalytic cysteine residues in the catalytic 
site. The catalytic triad of DGAT comprises of Cys112, 
His238, and Asn268. These residues are conserved in DGAT 
Type 2B (Cys113, His246, and Asn276). The enzyme DGAT 
Type 2B catalyzes carbon-carbon bond formation by 
condensing an acyl primer with an elongating carbon source 
often attached to a holo-ACP [19]. Hence, the primer binding 
site of DGAT is important to defining of substrate 
specificities. The isoformic structure was described 
elsewhere using the purification data reported by Kamisaka 
et al. [14]. It should be noted that the function of Type 2A is 
still unclear and inter conversion of inactive to active form of 
DGAT probably requires certain hormonal and/or 
biochemical and/or molecular modulator. We docked 
Sphingosine, Trifluoroperazine, PhosphatidicAcid, 
Lysophospatidylserine, KCl and 1, 2-diolein to DGAT type 
2B. These are lavonoids (a group of polyphenolic 
compounds) are widely distributed through out the plant 
kingdom with antibacterial activity. The interactions of these 
compounds with DGAT type 2B are described. 
 
 
Figure 1: Model of Maretierella ramanniana DGAT (a) type 2A and (b) type 2B developed using MODELLER. Bioinformation by Biomedical Informatics Publishing Group               open access 
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Figure 2: Docking models of several inhibitors with DGAT2B (a) Sphingosine; (b) Trifluoroperazine; (c) Phosphatidic acid; (d) 
Lyso phospatidylserine; (e) KCl and (f) 1, 2-diolein. 
 
Ligand docking was carried out for DGAT Type 2B with 
these inhibitors (Figure: 2A – 2F). Lowest models of DGAT 
Type 2B in complex with inhibitors are shown in Figure 2A - 
2F. As shown in figure 2B, the side chains of Cys113, 
Phe308, Ser153 and Asn249 play important roles on 
hydrogen bonds with 7-, 4- and 4-hydroxyl groups of 
naringenin, respectively. However, in the case of 
phosphatidic acid, only the side chain of Ser153 forms 
hydrogen bond with 7-hydroxyl group of apigenin. The 
double bond of C2-C3 position of C ring in phosphatidic acid 
provides a structural rigidity compared with 
lysophospatidylserine. This rigidity interrupted an H-bond 
between DGAT Type 2B and Lysophospatidylserine. The 
results described here is in close resemblance to the data 
described elsewhere [14]. It is speculated that the outer 
membrane of fungus acts as a barrier against 
lysophospatidylserine. However, it has already been reported 
that the purified DGAT utilizes a broad range of molecular 
species of diacyl glycerol and acyl-CoA as substrates [14]. 
 
The highest activity of the purified enzyme was observed 
with sn-1, 2-diolein and lauroyl-CoA. Data show that anionic 
phospholipids such as phosphatidic acid (PA) activated the 
purified enzyme. Reports also show that sphingosine dose 
dependently inhibited DGAT activity activated by PA and 
basal activity without PA. These results explain for the 
molecular function of DGAT and the mechanism of tri-
acylglycerol biosynthesis.  
 
Conclusion 
The three-dimensional structure model of DGAT Type 2B 
was created and described. Ligand docking shows that 
lysophospatidylserine provides the proper binding model in 
active site of DGAT Type 2 B with intensive hydrogen 
bonding network. Nevertheless, the comprehensive studies 
pertaining to elucidation of structural and functional models 
of Type 2A of DGAT as well as other TG biosynthesis Bioinformation by Biomedical Informatics Publishing Group               open access 
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enzymes may provide new insights into the molecular 
mechanism of these key players in fungal biotechnology.  
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Supplementary material 
  
Inhibitors Energy 
Kcal/mol 
RMS Free 
energy 
Kcal/mol 
     KI  Inter  
molecular  
energy 
Internal  
energy 
Sphingosine -17.45  54.06  -13.15 2.31e-010  -18.13 0.68 
Trifluoroperazine -0.61  57.48  -15.31 6.02e-012  -17.18 16.56 
PhosphatidicAcid -10.99  57.48 -3.73  0.0  -11.51  0.52 
Lysophospatidylserine -16.22  51.09  -10.39 2.4e-008  -16.62 0.4 
KCl  -1.22  54.43  -1.22 0.13  -1.22 0.0 
Table1: Docking data of the protein DGAT 2A with different inhibitors is given. 
 
Docked energy (kcal/mol)  Inhibitors 
DGAT type 2A  DGAT type 2B 
Sphingosine -17.45  -16.26 
Trifluoroperazine -0.61 -1.51 
Phosphatidic Acid  -10.99  -12.59 
Lysophospatidylserine -16.22  -16.27 
KCl -1.22  -1.09 
1, 2-diolein  -16.02  -14.58 
Table 2: Screening data generated using AUTODOCK v 3.0.5. Docking energies of different inhibitors with diacylglycerol 
acyltransferase (DGAT) type 2A and type 2B from Umbelopsis ramanniana is given. 
 